Letko, Brosseau & Associates Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$59.9M |
| 2 |
LPNT
LifePoint Health, Inc.
LPNT
|
+$40.6M |
| 3 |
Biogen
BIIB
|
+$19.7M |
| 4 |
Magna International
MGA
|
+$6.2M |
| 5 |
Royal Bank of Canada
RY
|
+$2.64M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teck Resources
TECK
|
+$120M |
| 2 |
DMC
Del Monte Corp
DMC
|
+$78.4M |
| 3 |
Johnson & Johnson
JNJ
|
+$32M |
| 4 |
GE Aerospace
GE
|
+$16.4M |
| 5 |
Johnson Controls International
JCI
|
+$11.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.56% |
| 2 | Energy | 17.85% |
| 3 | Communication Services | 15.42% |
| 4 | Technology | 9.82% |
| 5 | Industrials | 7.4% |
Similar funds
Letko, Brosseau & Associates's Q3 2016 Portfolio in Review
As of Q3 2016, Letko, Brosseau & Associates held 106 positions worth $10.7B, up 2% from $10.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Letko, Brosseau & Associates withdrew a net $351M in Q3 2016, closing 7 positions and reducing 67 holdings. Its most notable exit was Del Monte Corp, an estimated $78.4M position sold in full.
By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 24% a quarter earlier, followed by Energy and Communication Services.
Against the trend, Letko, Brosseau & Associates opened a new position in Elevance Health worth $58.1M.
- Letko, Brosseau & Associates's largest Q3 2016 buy was Elevance Health: 463,970 shares worth $58.1M.
- Letko, Brosseau & Associates added most to LifePoint Health, Inc. in Q3 2016, an estimated $40.6M increase.
- Letko, Brosseau & Associates's biggest Q3 2016 reduction was Teck Resources, cutting an estimated $120M.
- Letko, Brosseau & Associates fully exited Del Monte Corp in Q3 2016, selling an estimated $78.4M.
- Letko, Brosseau & Associates's ten largest holdings make up 34% of its $10.7B portfolio in Q3 2016.
- Letko, Brosseau & Associates opened 1 new position and closed 7 in Q3 2016.
- Letko, Brosseau & Associates's portfolio value rose 2% quarter-over-quarter to $10.7B.
Based on Letko, Brosseau & Associates's 13F filing for Q3 2016, filed 14 Nov 2016.